KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 75 days ( -1,245.71 % )
Last Price $4.71 0 %
High/ Low $4.71 - $4.71 0%
Chg 7 Days N/A $4.71 $4.71
Chg 30 Days N/A $4.71 $4.71
Chg 12 mos 861.22 % $0.490 $4.71
Trend - 3 mos -3.48 % Width: 21.65 %
Trend - 12 mos 100.01 % Width: 463.74 %
Pred. range - 3 mos $4.37 - $5.32 -7.22 % - 12.87 %
Pred. range - 12 mos $3.51 - $19.77 -25.53 % - 319.80 %
Short MA avg 3 mos Sell Jan 24, 2023 - 60 days
Long MA avg 3 mos Sell Mar 02, 2023 - 34 days
Short/Long MA avg 3 mos Sell Mar 02, 2023 - 34 days
Short MA avg 12 mos Sell Jan 27, 2023 - 57 days
Long MA avg 12 mos Buy Dec 30, 2022 - 75 days
Short/Long MA avg 12 mos Buy Jan 06, 2023 - 71 days
Pivot Short Buy Jan 27, 2023 - 57 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Idera Pharmaceuticals

Idera Pharmaceuticals Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a col... IDRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT